GOOD
INDIA
ANDHRA PRADESH
Natco Pharma gets USFDA’s EIR for Visakhapatnam plant

August inspection drew four Form-483 observations; regulator classifies as Voluntary Action Indicated
Read the original at The Hindu BusinessLine ↗
August inspection drew four Form-483 observations; regulator classifies as Voluntary Action Indicated
Read the original at The Hindu BusinessLine ↗